SureTrader Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, TheDane, BooDog, KarinCA, noretreat, TOB
Search This Board:
Last Post: 11/25/2015 2:50:42 AM - Followers: 672 - Board type: Free - Posts Today: 9

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


The above link is kept updated.

Ongoing Human Trials:
Product Pipeline:


Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Quarterly Report (10-q) 11/09/2015 04:13:18 PM
CTIX News: Current Report Filing (8-k) 11/03/2015 05:26:56 PM
CTIX News: Additional Proxy Soliciting Materials (definitive) (defa14a) 11/02/2015 06:07:08 AM
CTIX News: Proxy Statement (definitive) (def 14a) 10/28/2015 05:26:05 PM
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
#130877  Sticky Note $CTIX - Cellceutix Conducts Research on Retinoblastoma Cancer KarinCA 11/23/15 09:00:52 AM
#130867  Sticky Note Cellceutix Receives FDA Orphan Drug Designation for Kevetrin BigKahuna 11/23/15 07:43:19 AM
#129890  Sticky Note 11-11-15 $CTIX ~ Cellceutix Corp. Due Diligence Report TheHound 11/11/15 08:42:37 PM
#121761  Sticky Note Cellceutix Announces Filing of its Annual Report on TOB 09/14/15 09:28:06 AM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#131156   Translation -- "Even though we have now figured Waverunner1 11/25/15 02:50:42 AM
#131155   Good work LR. thefamilyman 11/25/15 02:12:40 AM
#131154   Preposterous. He has no idea what he Waverunner1 11/25/15 02:09:25 AM
#131153   The past, present and and future are all Rdunn88 11/25/15 01:55:58 AM
#131152   Good point! Some tend to focus on progress rule_rationale 11/25/15 01:02:32 AM
#131151   Fair enough. Uplisting is the one thing that sox040713 11/25/15 12:47:06 AM
#131150   Rosen had a few months to dig up Rdunn88 11/25/15 12:43:15 AM
#131149   Thanks Youssef - I can't make it this djs7 11/25/15 12:32:22 AM
#131148   Sox, An up-listing "without a RS" would have Rdunn88 11/25/15 12:06:05 AM
#131147   I thank you LR. You certainly have F1ash 11/24/15 11:54:47 PM
#131146   Right. Your first paragraph I think shows scottsmith 11/24/15 10:42:41 PM
#131145   Just wondering how you know that the legal sox040713 11/24/15 10:37:46 PM
#131144   That's a memory test that I'm not ready loanranger 11/24/15 10:36:11 PM
#131143   Is that 10-20 million shares at .70 or scottsmith 11/24/15 10:34:49 PM
#131142   Won't be too bad. 10-20 million shares from Phteven C 11/24/15 10:27:38 PM
#131141   Correct me if I'm wrong, and I know scottsmith 11/24/15 10:23:37 PM
#131140   I've said previously that the Sullivan letter's purpose, loanranger 11/24/15 10:20:24 PM
#131139   Actually this will get ugly - Rosen's defense Amatuer17 11/24/15 10:18:33 PM
#131138   Lol, I agree grizzlyman 11/24/15 10:18:17 PM
#131137   Ty Loanranger... grizzlyman 11/24/15 10:14:19 PM
#131136   This stuff drives me nuts....and it's not just loanranger 11/24/15 10:10:54 PM
#131135   Lol at writing Sullivan can't collect a legal scottsmith 11/24/15 09:52:30 PM
#131134   Thanks for that it's certainly ugly but what bradfordbros 11/24/15 09:48:01 PM
#131133   Can I bitch and moan about the fact loanranger 11/24/15 09:36:53 PM
#131132   And along came the LR...oh well it was 1400 11/24/15 09:30:42 PM
#131131   Can you post the response? grizzlyman 11/24/15 09:18:03 PM
#131130   I've been watching the Rosen site and companies TheHound 11/24/15 09:09:56 PM
#131129   I am sure you are right, wishful thinking Jhawker 11/24/15 09:03:11 PM
#131128 TheHound 11/24/15 09:00:15 PM
#131127   Don't have a clue but I hope it's Jhawker 11/24/15 08:57:34 PM
#131126   I'm sure you recognize the problem. It seems loanranger 11/24/15 08:55:35 PM
#131125   lol. :-) got it. TheHound 11/24/15 08:54:14 PM
#131124   They dropped it???!!!! bradfordbros 11/24/15 08:53:36 PM
#131123   Any clue as to why they're no longer listed? TheHound 11/24/15 08:52:38 PM
#131122   It's not on their News and Legal Updates bradfordbros 11/24/15 08:51:54 PM
#131121   Don't know but if you push the red Jhawker 11/24/15 08:50:06 PM
#131120   Question: Did the 10k need to show cascott 11/24/15 08:49:02 PM
#131119   If it's not on their website where does TheHound 11/24/15 08:40:07 PM
#131118   Well considering they're now past the deadline to TheHound 11/24/15 08:36:54 PM
#131117   It wouldn't make sense since it was a ErnieBilco 11/24/15 08:26:34 PM
#131116   I haven't seen you praised Leo. Just criticisms sox040713 11/24/15 08:26:24 PM
#131115   This is what I was looking at in SJ2016 11/24/15 08:25:58 PM
#131114   Correct. bradfordbros 11/24/15 08:21:39 PM
#131113   The piont is that it's not on their website. Jhawker 11/24/15 08:19:06 PM
#131112   Well, "Liquid Holdings Group, Inc." and "Shiloh Industries lousy engineer 11/24/15 08:18:27 PM
#131111   Nothing due that I'm aware of. TheHound 11/24/15 08:16:29 PM
#131110   Nope. Google. "Rosen CTIX". TheHound 11/24/15 08:13:25 PM
#131109   Did you get that from a cached page? bradfordbros 11/24/15 08:11:06 PM
#131108 TheHound 11/24/15 07:59:31 PM
#131107   He writes like a baby. bradfordbros 11/24/15 07:59:19 PM